Active Pharmaceutical Ingredient(API)

API PRODUCT LIST
Commercial Products
S.No Products CAS no. Specification
1 Gefitinib 184475-35-2 EP/IP
2 Imatinib Mesylate 152459-95-5 EP/IP
3 Cytarabine 147-94-4 EP/IP
4 Gemcitabine HCl 122111-03-9 EP/IP
5 Letrozole 112809-51-5 EP/IP
6 Anastrozole 120511-73-1 USP/EP/IP
7 Sorafenib 284461-73-0 EP/IP
8 Abiraterone Acetate 154229-18-2 USP/IP
9 Azacitadine 320-67-2 IP
10 Bicalutamide  90357-06-5 EP
11 Bortezomib 179324-69-7 IH
12 Busulfan 55-98-1 USP/IP
13 Capecitabine 154361-50-9 USP/IP
14 Cyclophosphamide 50-18-0 EP/IP
15 Dasatinib 302962-49-8 IH
16 Erlotinib 183321-74-6 IP
17 Oxaliplatin 61825-94-3 USP
18 Carboplatin 41575-94-4 USP/EP/IP
19 Carmustine 154-93-8 EP
20 Temozolamide 85622-93-1 EP/IP
21 Irinotecan HCl Trihydrate 136572-09-3 EP/IP
Products in pipeline
S.No Products CAS no. Specification
1 Sunitinib 557795-19-4 USP/BP/IP
2 Afatinib 850140-72-6 USP/BP/IP
3 Axitinib 319460-85-0 USP/BP/IP
4 Bendamustine HCl 3543-75-7 USP/BP/IP
5 Cisplatin 15663-27-1 USP/BP/IP
6 Carfilozomib 868540-17-4 USP/BP/IP
7 Decitabine 2353-33-5 USP/BP/IP
8 Methotrexate. 59-05-2 USP/BP/IP
9 Doxorubicin HCl 25316-40-9 USP/BP/IP
10 Enzalutamide 915087-33-1 USP/BP/IP
11 Epirubicin HCl 56390-09-1 USP/BP/IP
12 Etoposide 33419-42-0 USP/BP/IP
13 Exemestane 107868-30-4 USP/BP/IP
14 Lapatinib 388082-78-8 USP/BP/IP
15 Lenalidomide 191732-72-6 USP/BP/IP
16 Pazopanib HCl 635702-64-6 USP/BP/IP
17 Tamoxifen Citrate 54965-24-1 USP/BP/IP
18 5-Fluorouracil 17902-23-7 USP/BP/IP
19 Paclitaxel 33069-62-4 USP/BP/IP
20 Pazopanib HCl 635702-64-6 USP/BP/IP
21 Pemetrexed Disodium
Heptahydrate		 357166-29-1 USP/BP/IP